"Datamonitor’s Pharmaceuticals in France industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
* Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of the industry’s recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes a five-year forecast of the industry
* The leading companies are profiled with supporting key financial metrics
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by value and/or volume
* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
* Market shares are covered by manufacturer or brand
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.
For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.
Europe comprises Belgium, France, Germany, Italy, Netherlands, Spain, Sweden and the UK.
Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
The global figure comprises the Americas, Asia-Pacific and Europe.
Table of Contents
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 14
6.3 Supplier Power 15
6.4 New Entrants 17
6.5 Substitutes 18
6.6 Rivalry 19
CHAPTER 7 Leading Companies 20
7.1 Sanofi-Aventis 20
7.2 GlaxoSmithKline Plc 22
7.3 Pfizer Inc 26
7.4 AstraZeneca 28
CHAPTER 8 Market Forecasts 31
8.1 Market Value Forecast 31
CHAPTER 9 Macroeconomic Indicators 32
CHAPTER 10 Appendix 34
10.1 Methodology 34
10.2 Industry Associations 35
10.3 Related Datamonitor Research 35
LIST OF TABLES
Table 1: France Pharmaceuticals Market Value: $ million, 2003-2007 9
Table 2: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10
Table 3: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11
Table 4: France Pharmaceuticals Market Share: % Share, by Value, 2007 12
Table 5: Key Facts: Sanofi-Aventis 20
Table 6: Key Financials: Sanofi-Aventis 21
Table 7: Key Facts: GlaxoSmithKline Plc 22
Table 8: Key Financials: GlaxoSmithKline Plc 25
Table 9: Key Facts: Pfizer Inc 26
Table 10: Key Financials: Pfizer Inc 27
Table 11: Key Facts: AstraZeneca Plc 28
Table 12: Key Financials: AstraZeneca Plc 30
Table 13: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012 31
Table 14: France Size of Population (million) , 2003-2007 32
Table 15: France GDP (Constant 2000 Prices, $ billion), 2003-2007 32
Table 16: France Inflation, 2003-2007 32
Table 17: France Exchange Rate, 2003 33
"
Pages: 35
|
